FoxO3 activation in hypoxic tubules prevents chronic kidney disease
Open accessThe DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Acute kidney injury (AKI) can lead to chronic kidney disease (CKD) if injury is severe and/or repair is incomplete. However, the pathogenesis of CKD following renal ischemic injury is not fully understood. Capillary rarefaction and tubular hypoxia are common findings during the AKI to CKD transition. We investigated the tubular stress response to hypoxia and demonstrated that a stress responsive transcription factor, FoxO3, was regulated by prolyl hydroxylase. Hypoxia inhibited FoxO3 prolyl hydroxylation and FoxO3 degradation, thus leading to FoxO3 accumulation and activation in tubular cells. Hypoxia-activated Hif-1α contributed to FoxO3 activation and functioned to protect kidneys, as tubular deletion of Hif-1α decreased hypoxia-induced FoxO3 activation, and resulted in more severe tubular injury and interstitial fibrosis following ischemic injury. Strikingly, tubular deletion of FoxO3 during the AKI to CKD transition aggravated renal structural and functional damage leading to a more profound CKD phenotype. We showed that tubular deletion of FoxO3 resulted in decreased autophagic response and increased oxidative injury, which may explain renal protection by FoxO3. Our study indicates that in the hypoxic kidney, stress responsive transcription factors can be activated for adaptions to counteract hypoxic insults, thus attenuating CKD development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“One report demonstrated that chronic hypoxia after severe ischaemic AKI activated FOXO3 in a HIF1α-dependent manner105.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [105]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Compared with wild-type controls, mice with a proximal tubule-specific Foxo3 deletion failed to induce autophagy in kidney tubules after AKI.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [105]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The expression of BNIP3, a known target of FOXO3 and a key component of the autophagy machinery, was also decreased in Foxo3-knockout mice, whereas ULK1 expression was only slightly reduced.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [105]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These results suggest a potential role for the HIF1α–FOXO3 pathway in regulating tubular cell autophagy during the transition from AKI to CKD105.”
From Autophagy in kidney homeostasis and disease (2020) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to Hypoxia
Zhang, H., Bosch-Marce, M., Shimoda, L. A., Tan, Y. S., Baek, J. H., Wesley, J. B., Gonzalez, F. J., & Semenza, G. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800102200 · Cited by 1,601
RetractedMartinez, J., Almendinger, J., Oberst, A., Ness, R., Dillon, C. P., Fitzgerald, P., Hengartner, M. O., & Green, D. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113421108 · Cited by 655
RetractedMartinez, J., Cunha, L. D., Park, S., Yang, M., Lu, Q., Orchard, R., Li, Q.-Z., Yan, M., Janke, L., Guy, C., et al. (2016) · Nature · doi:10.1038/nature17950 · Cited by 381
RetractedZhang, S., Zhao, Y., Xu, M. G., Li, Y., Zhao, Y., Chen, J., Yuan, Y., Zheng, Q., & Niu, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080342 · Cited by 57 · cited 1×
“As observed in MEFs, endothelial cells, and some other cell types (21, 22), we found that FoxO3 activation in renal tubular cells was partially dependent on HIF-1α, as deletion of HIF-1α blunted FoxO3 accumulation.”
BackgroundRetractedAkt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
De Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645 · cited 1×
“HIF-1 protein is critical for rapid as well as long-term adaptations to hypoxia (68).”
BackgroundAutophagy and the Integrated Stress Response
Kroemer, G., Mariño, G., & Levine, B. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.023 · Cited by 3,506 · cited 1×
“Signals for autophagy induction can be transduced to the nutrient and energy sensors that include AMPK, mTORC1, and NADH-dependent deacetylases of the sirtuin family, as well as other molecular pathways that involve stress responses (42, 43).”
BackgroundTargeting the KEAP1-NRF2 system to prevent kidney disease progression
Nezu, M., Suzuki, N., & Yamamoto, M. (2017) · American Journal of Nephrology · doi:10.1159/000475890 · Cited by 3,447
Cited by
Autophagy in kidney homeostasis and disease
Tang, C., Livingston, M. J., Liu, Z., & Dong, Z. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0309-2 · Cited by 496
Song, X., Liu, J., Kuang, F., Chen, X., Zeh, H. J., Kang, R., Kroemer, G., Xie, Y., & Tang, D. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108767 · Cited by 260
Protein Hydroxylation by Hypoxia-Inducible Factor (HIF) Hydroxylases: Unique or Ubiquitous?
Strowitzki, M., Cummins, E., & Taylor, C. (2019) · Cells · doi:10.3390/cells8050384 · Cited by 247
“Moreover, the upregulation of FOXO3a seems to be part of the protective cellular stress response by inducing autophagic activity in renal epithelial cells during hypoxia and subsequent renal injury [106,107].”
BackgroundLivingston, M. J., Shu, S., Fan, Y., Li, Z., Jiao, Q., Yin, X.-M., Venkatachalam, M. A., & Dong, Z. (2023) · Autophagy · doi:10.1080/15548627.2022.2072054 · Cited by 230
“Compared with wild-type mice, induction of autophagy in renal tubules after AKI is inhibited in proximal tubule-specific Foxo3 knockout mice, suggesting a role of the hypoxia inducible factor 1-FOXO3 pathway in tubular cell autophagy during kidney repair [44].”
BackgroundZhang, C., Shang, Y., Chen, X., Midgley, A. C., Wang, Z., Zhu, D., Wu, J., Chen, P., Wu, L., Wang, X., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c05681 · Cited by 212
Choi, M. E. (2020) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021119-034658 · Cited by 150
“The stress-responsive transcription factor FoxO3 was activated in kidney tubular epithelial cells in response to hypoxia, resulting from the inhibition of FoxO3 prolyl hydroxylation and the activation of hypoxia-inducible factor (HIF)-1α (91).”
BackgroundAcute kidney injury and maladaptive tubular repair leading to renal fibrosis
Yu, S. M.-W., & Bonventre, J. V. (2020) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000605 · Cited by 160
Molecular Interactions Between Reactive Oxygen Species and Autophagy in Kidney Disease
Kaushal, G. P., Chandrashekar, K., & Juncos, L. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153791 · Cited by 134
“Hypoxia-activated HIF-1α contributes to FOXO3 activation and functions to protect the kidneys, since tubular deletion of HIF-1α decreased FOXO3 activation and caused more severe tubular injury and interstitial fibrosis, suggesting that FOXO3 activation protects kidneys from IR injury [173].”
BackgroundKim-1 Targeted Extracellular Vesicles: A New Therapeutic Platform for RNAi to Treat AKI
Tang, T., Wang, B., Li, Z., Wen, Y., Feng, S., Wu, M., Liu, D., Cao, J.-Y., Yin, Q., Yin, D., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020111561 · Cited by 142
“To evaluate kidney injury score, three random tissue sections per mouse were assessed on the basis of periodic acid–Schiff (PAS) staining and scored using ImageJ software (National Institutes of Health).(33) Briefly, a graticule grid consisting of 100 grids was superimposed on each image (320 magnification).”
MethodProtecting the kidney in systemic lupus erythematosus: from diagnosis to therapy
Maria, N. I., & Davidson, A. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0401-9 · Cited by 128
Li, X., Zou, Y. S., Xing, J., Fu, Y., Wang, K., Wan, P., & Zhai, X. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6286984 · Cited by 178
“Another study has also shown that preischemic targeting of HIF prolyl hydroxylation inhibits fibrosis caused by renal IRI, while postischemic PHD inhibition does not impact AKI-associated fibrosis [44].”
BackgroundAutophagy Function and Regulation in Kidney Disease
Kaushal, G. P., Chandrashekar, K., Juncos, L. A., & Shah, S. V. (2020) · Biomolecules · doi:10.3390/biom10010100 · Cited by 118
Yeh, T.-H., Tu, K.-C., Wang, H., & Chen, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031755 · Cited by 120
“On the contrary, some authors have found that under hypoxia conditions HIF-1 α binds to FoxO3, which is thought to be a renoprotection factor after AKI, and subsequently inhibits the hydroxylation and degradation of FoxO3 [103].”
BackgroundMitochondria bridge HIF signaling and ferroptosis blockage in acute kidney injury
Li, W., Xiang, Z., Xing, Y., Shen, L., & Shi, S. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04770-4 · Cited by 92
“Interestingly, FoxO3 activation was induced by hypoxia and HIF-1 in AKI [102].”
BackgroundRole of Renal Hypoxia in the Progression From Acute Kidney Injury to Chronic Kidney Disease
Ullah, M. M., & Basile, D. P. (2019) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2019.10.006 · Cited by 89
Autophagy at the intersection of aging, senescence, and cancer
Cassidy, L. D., & Narita, M. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13269 · Cited by 84
FoxO3 and oxidative stress: a multifaceted role in cellular adaptation
Bernardo, V. S., Torres, F. F., & da Silva, D. G. H. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02281-5 · Cited by 88
Chen, J., Huang, M., Chen, X., Wu, L., Li, Q., Hong, Q., Wu, J., Li, F., Chen, L.-M., Dong, Y., et al. (2022) · Theranostics · doi:10.7150/thno.73426 · Cited by 86
“To clarify the tubular location of EGR1, we performed co-staining of the kidney tubules for EGR1 with various markers, lotus teragonolobus lectin (LTL, a proximal tubule marker), peanut agglutinin (PNA, a henle/distal tubule loop marker), dolichos biflorus agglutinin (DBA, a collecting duct marker), aquaporin 2 (AQP2,…”
MethodLongevity Factor FOXO3: A Key Regulator in Aging-Related Vascular Diseases
Zhao, Y., & Liu, Y. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.778674 · Cited by 83
Autophagy and its therapeutic potential in diabetic nephropathy
Han, Y.-P., Liu, L., Yan, J.-L., Chen, M., Meng, X., Zhou, X., & Qian, L.-B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1139444 · Cited by 74
“Deficiency of HIF-1a has been reported to aggravate renal dysfunction (150), while up-regulation of HIF-1a effectively enhances autophagy to mitigate DN, which may associate with the increased expression of Sirt1, FoxO3, and BNIP3 (119, 151, 152).”
BackgroundInfluentialJiang, A., Liu, J., Wang, Y., & Zhang, C. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.09.011 · Cited by 62
Lactoferrin Contributes a Renoprotective Effect in Acute Kidney Injury and Early Renal Fibrosis
Hsu, Y., Chiu, I., Lin, Y., Chen, Y., Lee, Y., & Chiu, H. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12050434 · Cited by 69
Zhu, S., Zhou, W., Niu, Y., Zheng, C., Liu, X., Zhang, Y., & Yu, C. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01098-3 · Cited by 68
“Mitochondrial superoxide ROS (mtROS) detection mtROS production was assessed by incubating freshly prepared snap-frozen sections and cells with 5 μM MitoSOX Red fluorescent probe (M36008, Invitrogen, USA) for 10 min at 37 °C in darkness [27, 28].”
MethodKe, Q., Yuan, Q., Qin, N., Shi, C., Luo, J., Fang, Y., Xu, L., Sun, Q., Zen, K., Jiang, L., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-019-2219-4 · Cited by 59
Contribution of Oxidative Stress to HIF‐1‐Mediated Profibrotic Changes during the Kidney Damage
Zhang, H., Xu, R., & Wang, Z. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6114132 · Cited by 62
“In addition, HIF-1 has been found to contribute to the activation of forkhead box O3, leading to increased autophagy and reduced oxidative damage, thus playing a role in renal protection [94].”
BackgroundXu, C., Ha, X., Yang, S., Tian, X., & Jiang, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1232790 · Cited by 69
Lei, J., Wang, S., Wang, K., Chu, Q., Liu, Z., Sun, L., Ji, Y. B., Esteban, C. R., Yao, Y., Belmonte, J. C. I., et al. (2020) · Protein & Cell · doi:10.1007/s13238-020-00779-7 · Cited by 51
Gu, X., Yang, H., Sheng, X., Ko, Y.-A., Qiu, C., Park, J., Huang, S., Kember, R. L., Judy, R., Park, J., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz1458 · Cited by 58
“Genetic deletion of autophagy regulators such as Atg5 and Atg7 in kidney tubules indicated an important role for autophagy in TEC health and protection from injury (21, 35, 36).”
BackgroundRecent Update on Acute Kidney Injury-to-Chronic Kidney Disease Transition
Koh, E. S., & Chung, S. (2024) · Yonsei Medical Journal · doi:10.3349/ymj.2023.0306 · Cited by 64
“76 Recently, Li, et al. 77 revealed that under hypoxia, HIF-1a can bind to Forkhead box O3 (FoxO3), a stress-responsive transcription factor known to upregulate autophagy after UUO, subsequently suppressing prolyl hydroxylation and degradation of FoxO3 by the ubiquitin-proteasome system.”
Wu, M., Chen, W., Miao, M., Jin, Q., Zhang, S., Bai, M., Fan, J., Zhang, Y., Zhang, A., Jia, Z., et al. (2021) · Clinical Science · doi:10.1042/cs20210100 · Cited by 52
Zheng, H., Zhang, Y., He, J., Yang, Z., Zhang, R., Li, L., Luo, Z., Ye, Y., & Sun, Q. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.645100 · Cited by 45
“The incidence of AKI is rising, and patients with severe AKI have a mortality rate of >50% (1, 2).”
BackgroundSelf-citationJuszczak, F., Arnould, T., & Declèves, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136936 · Cited by 48
“Indeed, tubular-specific deletion of FOXO3a in the mouse kidney resulted in a more drastic oxidative injury in response to I/R when compared to control mice [149].”
BackgroundShi, M., Maique, J., Shepard, S., Li, P., Seli, O., Moe, O. W., & Hu, M. C. (2021) · Kidney International · doi:10.1016/j.kint.2021.09.030 · Cited by 42
Li, F., Wei, R., Huang, M., Chen, J., Li, P., Ma, Y., & Chen, X. (2022) · Food & Function · doi:10.1039/d2fo02477b · Cited by 45
Meng, F., Zhang, Z., Chen, C., Liu, Y., Yuan, D., Hei, Z., & Luo, G. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119119 · Cited by 40
FOXO3 is a latent tumor suppressor for FOXO3-positive and cytoplasmic-type gastric cancer cells
Tsuji, T., Maeda, Y., Kita, K., 村上, 和., Saya, H., Takemura, H., Inaki, N., Oshima, M., & Oshima, H. (2021) · Oncogene · doi:10.1038/s41388-021-01757-x · Cited by 46
“Although, hypoxia-induced FOXO3 activation leads to tubular regeneration in acute kidney injury [30], the constitutive activation of FOXO3 in kidney tubular cells may cause growth arrest and apoptosis.”
BackgroundMakievskaya, C. I., Popkov, V. A., Andrianova, N. V., Liao, X., Zorov, D. B., & Plotnikov, E. Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032576 · Cited by 41
Autophagy in Cisplatin Nephrotoxicity during Cancer Therapy
Hu, X., Ma, Z., Wen, L., Li, S., & Dong, Z. (2021) · Cancers · doi:10.3390/cancers13225618 · Cited by 38
Autophagy in acute kidney injury and maladaptive kidney repair
Yu, X., Fu, Y., Wu, W., Tang, C., & Dong, Z. (2023) · Burns & Trauma · doi:10.1093/burnst/tkac059 · Cited by 41
“After ischemic AKI, HIF-1 is significantly activated and can act as a transcription factor to activate factor forkhead box O-3, which was suggested to reduce fibrosis by maintaining autophagy in tubule cells [72].”
BackgroundTubular β-catenin and FoxO3 interactions protect in chronic kidney disease
Khodo, S. N., Osaki, Y., Scarfe, L., Yang, H., Mignemi, M. P., Tonello, J. M., Saito‐Diaz, K., Neelisetty, S., Ivanova, A. V., Huffstater, T. M., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.135454 · Cited by 40
“It was recently reported that FoxO3 is protective in injured renal tubules through effects on autophagy and oxidative stress (64).”
BackgroundSmall molecules as modulators of regulated cell death against ischemia/reperfusion injury
Chen, D., Guo, Y. P., Li, X., Zhang, G., & Li, P. (2022) · Medicinal Research Reviews · doi:10.1002/med.21917 · Cited by 39
FOXO3a accumulation and activation accelerate oxidative stress‐induced podocyte injury
Chen, X., Liu, W., Xiao, J., Zhang, Y., Chen, Y., Luo, C., Huang, Q., Peng, F., Gong, W., Li, S., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202000783r · Cited by 38
Sánchez‐Navarro, A., Pérez‐Villalva, R., Murillo‐de‐Ozores, A. R., Martínez-Rojas, M. A., Rodríguez‐Aguilera, J. R., González, N., Castañeda‐Bueno, M., Gamba, G., Targa, F. R., & Bobadilla, N. A. (2021) · Scientific Reports · doi:10.1038/s41598-021-88000-5 · Cited by 36
Zhao, G., Zhang, H., Zhu, S., Wang, S., Zhu, K., Zhao, Y., Xu, L., Zhang, P., Xie, J., Sun, A., et al. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110141 · Cited by 35
Loeb, G. B., Kathail, P., Shuai, R. W., Chung, R., Grona, R. J., Peddada, S., Sevim, V., Federman, S. M., Mader, K., Chu, A. Y., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01904-6 · Cited by 36
Li, Z., Wang, B., Lv, L., Tang, T., Wen, Y., Cao, J.-Y., Zhu, X., Feng, S., Crowley, S. D., & Liu, B. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00617-4 · Cited by 37
Guo, L.-J., Chen, S., Ou, L., Li, S., Ye, Z.-N., & Liu, J. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s369090 · Cited by 36
“This may explain the renal protective effect of FOXO on attenuating chronic kidney disease development.(65)”
BackgroundBrandt, S., Ballhause, T. M., Bernhardt, A., Becker, A., Șalaru, D. L., Le-Deffge, H. M., Fehr, A., Fu, Y., Philipsen, L., Djudjaj, S., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019121289 · Cited by 32
Liu, Y., Dong, Z.-J., Song, J.-W., Liang, L.-R., Sun, L.-L., Liu, X.-Y., Miao, R., Xu, Y.-L., Li, X.-T., Zhang, M.-W., et al. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113017 · Cited by 29
Molecular regulation and function of FoxO3 in chronic kidney disease
Lin, F. (2020) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000616 · Cited by 25
Self-citationTargeting autophagy using saponins as a therapeutic and preventive strategy against human diseases
Han, B., & He, C. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105428 · Cited by 26
Emerging Roles of Long Non-Coding RNAs in Renal Fibrosis
Lin, J., Jiang, Z., Liu, C., Zhou, D., Song, J., Liao, Y., & Chen, J. (2020) · Life · doi:10.3390/life10080131 · Cited by 28
Rodríguez-Pérez, J., Andreu-Martínez, R., Daza, R., Fernández-Arroyo, L., Hernández-García, A., Díaz‐García, E., Cubillos‐Zapata, C., Lozano-Díez, A., Morales, A., Ramos, D., et al. (2025) · Antioxidants · doi:10.3390/antiox14070839 · Cited by 38
“FOXO3 is another transcription factor regulated under hypoxia through prolyl hydroxylation [53].”
Yang, Y., Yuan, H., Yang, T., Li, Y., Gao, C., Jiao, T., Cai, Y., & Zhao, S. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.691592 · Cited by 28
Shang, J., Wang, L., Tan, L., Ren, P., Wu, D., Xia, Y., & Xu, P. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.07.126 · Cited by 22
Mouse Models of Kidney Fibrosis
Kramann, R., & Menzel, S. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1382-5_22 · Cited by 22
Expression profiles of tRNA‑derived fragments in high glucose‑treated tubular epithelial cells
Ji, J., Ju, R., Zheng, H., Shi, H., Qu, G., Li, S., Gan, W., & Zhang, A. (2022) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2022.11725 · Cited by 21
“Evidence has indicated that FoxO3 is an important player in fibrogenesis and a novel treatment strategy in renal fibrosis (47).”
Zhu, X., Lin, Q., Yang, Y., Li, S., Shao, X., Zhang, W., Cai, H., Li, J., Wu, J., Zhang, K., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05473-z · Cited by 25
“During renal hypoxia, tubular deletion of FoxO3 leads to decreased BNIP3 protein levels, autophagic response and increased mitochondrial dysfunc - tion and oxidative damage [ 21 ].”
InfluentialNagasaki, T., Maeda, H., Taguchi, K., Yanagisawa, H., Nishida, K., Kobayashi, K., Wada, N., Noguchi, I., Murata, R., Sakai, H., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102371 · Cited by 19
“reported that the HIF-1α protein levels were enhanced at 1–2 weeks after IR in kidney [78].”
BackgroundThe non-canonical functions of HIF prolyl hydroxylases and their dual roles in cancer
Yu, M., Lun, J., Zhang, H., Zhu, L., Zhang, G., & Fang, J. S. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.105982 · Cited by 22
Early triggers of moderately high‐fat diet‐induced kidney damage
Sánchez‐Navarro, A., Martínez-Rojas, M. A., Bohn, R. I. C., Pérez‐Villalva, R., Zambrano, E., Castro-Rodríguez, D. C., & Bobadilla, N. A. (2021) · Physiological Reports · doi:10.14814/phy2.14937 · Cited by 21
Liu, J., Livingston, M. J., Dong, G., Wei, Q., Zhang, M., Mei, S., Zhu, J., Zhang, C., & Dong, Z. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00458.2023 · Cited by 19
miR−122−5p Regulates Renal Fibrosis In Vivo
Kaneko, S., Yanai, K., Ishii, H., Aomatsu, A., Hirai, K., Ookawara, S., Ishibashi, K., & Morishita, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315423 · Cited by 16
“FOXO3 was reported to have anti−fibrotic functions in various organs including the kidney (described later) [27,41].”
BackgroundRegulation of Ptch1 by miR-342-5p and FoxO3 Induced Autophagy Involved in Renal Fibrosis
Tang, S., Wang, Y., Xie, G., Li, W., Chen, Y., Liang, J., Liu, P., Song, F., & Zhou, J. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.583318 · Cited by 16
“It has been shown that FoxO3 may attenuate the idiopathic pulmonary brosis myo broblast phenotype in vitro and bleomycin-induced lung brosis in vivo [34], prevent the progression of kidney diseases [35,36] and promote kidney injury after UUO[37].”
BackgroundZheng, H., Zhang, Y., Li, L., Zhang, R., Luo, Z., Yang, Z., Ye, Y., He, J., & Sun, Q. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.641527 · Cited by 19
“Acute kidney injury (AKI), first acknowledged as a syndrome over 70 years ago, primarily occurs due to ischemia-reperfusion injury (IRI), which is generally observed in renal allografts or following vascular surgery (Shu et al., 2018; Kishi et al., 2019; Li et al., 2019).”
BackgroundSelf-citationZhang, J., Shen, R., Lin, H., Pan, J., Feng, X., Lin, L., Niu, D., Hou, Y., Su, X., Wang, C., et al. (2022) · Renal Failure · doi:10.1080/0886022x.2022.2126790 · Cited by 17
“, the ischemia time of 35min induced moderate to severe injury [16].”
BackgroundInfluentialDarwish, S. F., Mahmoud, A. M. A., Mageed, S. S. A., Sallam, A.-A. M., & Oraby, M. A. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175908 · Cited by 14
The Role of MicroRNA in the Pathogenesis of Acute Kidney Injury
Bakinowska, E., Kiełbowski, K., & Pawlik, A. (2024) · Cells · doi:10.3390/cells13181559 · Cited by 16
“This molecule was found to enhance apoptosis in renal tubular epithelial cells and to target the forkhead box O3 (FoxO3) transcription factor [101], which plays a protective role in hypoxic renal injury by regulating autophagy and oxidative stress responses [102].”
BackgroundCoca, A., Bustamante‐Munguira, E., Fidalgo, V., Fernández, M., Abad‐Molina, C., Franco, M. C. C., González-Pinto, Á. T., Pereda, D., Cánovas, S., & Bustamante‐Munguira, J. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae229 · Cited by 13
“…and the formation of prostaglandin E2, or modulate the activity of antioxidant enzymes such as catalase or manganese superoxide dismutase [9 , 12 –14 ]. β - Hydroxybutyrate is also capable of protecting mitochondrial function and inhibiting hydroxyl radical activity that boosts oxidative…”
BackgroundRedefining SGLT2 inhibitors through cytoprotective mechanisms
Stanković, S., Miloradović, Z., Petrovič, V., & Stoiljković, M. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178647 · Cited by 13
Resilience to acute kidney injury in offspring of maternal protein restriction
García‐Ortuño, L. E., Barrera‐Chimal, J., Pérez‐Villalva, R., Ortega-Trejo, J. A., Luna-Bolaños, E., Lima‐Posada, I., Sánchez‐Navarro, A., Reyes‐Castro, L. A., Gamba, G., Zambrano, E., et al. (2019) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00356.2019 · Cited by 12
Hypoxia-Driven Responses in Chronic Kidney Disease
Miguel, V., & Rojo, A. (2023) · Oxygen · doi:10.3390/oxygen3030020 · Cited by 15
“In the hypoxic kidney, the stress-responsive transcription factor FoxO3 is activated in TECs likely as an adaptation to counteract hypoxic insults, attenuating CKD. Hypoxia inhibits FoxO3 prolyl hydroxylation and subsequent degradation, promoting autophagy and reducing oxidative injury [86].”
BackgroundDisturbance of Hypoxia Response and Its Implications in Kidney Diseases
Li, Z., Wang, B., Wen, Y., Wu, Q., Lv, L., & Liu, B. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0271 · Cited by 11
“Meanwhile, during ischemia/hypoxia-induced AKI, increased autophagic response in the tubules lowers the oxidative injury and attenuates the progression of interstitial fibrosis in an HIF-1 a –dependent manner (87).”
Going from acute to chronic kidney injury with FoxO3
Gu, X., Raman, A., & Suszták, K. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128985 · Cited by 11
SerpinA3K Deficiency Reduces Oxidative Stress in Acute Kidney Injury
González‐Soria, I., Soto-Valadez, A. D., Martínez-Rojas, M. A., Ortega-Trejo, J. A., Pérez‐Villalva, R., Gamba, G., Sánchez‐Navarro, A., & Bobadilla, N. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097815 · Cited by 12
“The transcription factor FOXO3 plays an important role in the resistance against oxidative stress induced by AKI, through inducing antioxidant enzymes [35,36].”
BackgroundPHD3 inhibits colon cancer cell metastasis through the occludin-p38 pathway
Li, Y., Yuan, T., Zhang, H., Liu, S., Lun, J., Guo, J., Wang, Y., Zhang, Y., & Fang, J. S. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023103 · Cited by 10
“PHD3 mediates the oxygen-dependent stability of activating transcription factor 4 [6], 2-adrenergic receptor [7], transcription factor paired box 2 [8], Sprouty2 protein [9], actin [10], erythropoietin receptor [11], FOXO3 [12], MAPK6 [13] and p53 [14].”
Choi, S., Kim, D. Y., Ahn, Y., Lee, E. J., & Park, J. H. (2021) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2020.197 · Cited by 10
“In addition, hypoxia-activated HIF1 α controlled the late phase of renal tubular repair by FOXO3 activation, which finally contributed to functional recovery (Li et al ., 2019; Lin, 2020).”
Dynamic regulation of proximal tubular autophagy from injury to repair after ischemic kidney damage
Gong, Y., Zhu, W., Li, Y., Lu, T., Tan, J., He, C., Yang, L., Zhu, Y., & Gong, L. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00663-w · Cited by 12
FoxO3 Regulates the Progress and Development of Aging and Aging-Related Diseases
Chang, Z., He, Z., & Xia, J. (2022) · Current Molecular Medicine · doi:10.2174/1566524023666221014140817 · Cited by 10
MondoA and AKI and AKI-to-CKD Transition
Maeda, S., Sakai, S., Takabatake, Y., Yamamoto, T., Minami, S., Nakamura, J., Namba‐Hamano, T., Takahashi, A., Matsuda, J., Yonishi, H., et al. (2024) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000414 · Cited by 9
“Current studies present con fl icting information on the role of autophagy during the recovery phase, some demonstrating that it slows CKD progression 53,54 and others reporting that it exacerbates CKD progression.”
Hanai, S., Uchimura, K., Takahashi, K., Ishii, T., Mitsui, T., & Furuya, F. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej21-0245 · Cited by 11
“Furthermore, a recent study indicated that in the hypoxic kidney, stress responsive transcription factors can be activated as an adaption to counteract hypoxic injury, thus attenuating CKD devel‐ opment [7].”
BackgroundWu, P., Li, X., Long, W., Ma, Y., Xue, B., Xie, W., & Ma, X. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2557514 · Cited by 14
“HIF-1α can mitigate the progression of CKD by inducing transcription factors such as FoxO3 [101,197].”
Xu, M.-R., Jin, C., Lu, J., Li, M., & Li, L. (2023) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3672 · Cited by 8
Self-citationChen, L., Chen, G., & Kong, X. (2021) · Medicine · doi:10.1097/md.0000000000024275 · Cited by 8
“Chronic kidney disease (CKD) has become a public health problem worldwide that is characteristic with high treatment costs and poor prognosis.([1]) Recently, cardiovascular complications are the most common cause of morbidity and mortality for patients with end-stage renal disease (ESRD),([2]) besides, systemic inflam…”
BackgroundYang, J. C.-S., Huang, L.-H., Wu, S.-C., Wu, Y.-C., Wu, C.-J., Lin, C.-W., Tsai, P.-Y., Chien, P.-C., & Hsieh, C.-H. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s350421 · Cited by 7
Deng, H., Lin, J., Jiang, Y., Amhare, A. F., Qiao, L., Wang, J., & Han, J. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118797 · Cited by 8
Prostacyclin Mitigates Renal Fibrosis by Activating Fibroblast Prostaglandin I2 Receptor
Li, J., Guan, Y., Xu, Y., Cao, Y., Xie, Q., Harris, R. C., Breyer, M. D., Lü, L., & Hao, C. (2023) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000000000286 · Cited by 8
“23,24 On day 56 after I/R, the kidneys of BPS-treated mice showed signi fi cantly lower protein levels of fi bronectin, COL1A1, and a -SMA and reduced the deposition of ECM as shown by Masson ’ s trichrome staining (Figure 4, B –”
BackgroundChen, Y., Wen, P., Yang, J., & Niu, J. (2020) · Kidney Diseases · doi:10.1159/000505156 · Cited by 7
Ni, W., Li, Z., Wen, X., Ji, J., Liu, H., Yin, Q., Jiang, L., Zhang, Y., Wen, Y., Tang, T., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16358 · Cited by 7
“Sample preparation and immunoblotting (IB) analyses were performed as described previously (Li, Kang, et al., 2019).”
Dang, C., Wang, D., Liu, P., Liu, J., & Yu, X. (2022) · Medicine · doi:10.1097/md.0000000000030417 · Cited by 7
“RAS-associated protein 1 (RAP1) is composed of RAP1A, RAP1B two heterodimers, FOXO3 can resist the damage of HIF1-α, and also promotes methylation of the endometrium and placenta formation.[38,39] It was found that RAP1 can activate the FOXO3 pathway,[40] and also promote the growth of ovarian tissue, increase the lev…”
BackgroundThe AMPK/NRF2/FOXO Axis in CKD—Molecular and Clinical Perspectives
Lučić, I., Vojković, M., & Milković, L. (2026) · Antioxidants · doi:10.3390/antiox15040409 · Cited by 4
“During progressive hypoxia in tubular cells, the inhibition of prolyl hydroxylase (PHD)-dependent degradation of FOXO3 allows its accumulation in the nucleus, where it activates a robust autophagic response (via Ulk1, Beclin-1, and Atg9A) and antioxidant defenses (via SOD2) [13,111,112].”
InfluentialProximal Tubular Transcription Factors in Acute Kidney Injury: Recent Advances
Piret, S. E., & Mallipattu, S. K. (2020) · The Nephron journals/Nephron journals · doi:10.1159/000508856 · Cited by 7
PHD3 inhibits cell proliferation through hydroxylation of PAX2 at proline 9
Lun, J., Wang, Y., Gao, Q., Wang, Y., Zhang, H., & Fang, J. S. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022043 · Cited by 4
“PKM2 [13], Spry2 [14], actin [15], ceramide kinase like protein (CERKL) [16], thyroid hormone receptor α (TRα) [17], erythropoietin receptor (EPOR) [18], MAPK6 [19], p53 [20], FOXO3 [21], and acetyl-CoA carboxylase 2 (ACC2) [22] were also found to be the targets of PHD3.”
BackgroundEffects of hypoxia on bone metabolism and anemia in patients with chronic kidney disease
Kan, C., Xu, L., & Zhang, R. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i34.10616 · Cited by 3
Chen, J., Xu, Y., Wu, P., Chen, X., Weng, W., & Li, D. (2022) · World Neurosurgery · doi:10.1016/j.wneu.2022.04.009 · Cited by 3
Sun, Y., Hong, Y., Ning, L., Xiao, B., Ainiwaer, M., Jiang, Y., & Ji, Y. (2025) · The FASEB Journal · doi:10.1096/fj.202501265rr · Cited by 4
“Under hypoxic conditions, activated FOXO3 can directly bind to HIF-1α, suppressing the transcription of HIF- 1α-dependent genes and preventing intracellular ROS accumulation [64].”
Yang, J. C. (2026) · Seminars in Plastic Surgery · doi:10.1055/a-2780-1561 · Cited by 1
Bao, Y., Zhang, Y., Yang, Y., Chen, X., Lin, L., Fu, Y., Ji, L., & Li, C. (2020) · Research Square · doi:10.21203/rs.3.rs-107303/v1
“The pathological syndrome of CKD includes glomerular sclerosis (4), tubular atrophy (5), and interstitial brosis (6).”
BackgroundBao, Y., Zhang, Y., Yang, Y., Chen, X., Lin, L., Fu, Y., Ji, L., & Li, C. (2021) · Clinical Complementary Medicine and Pharmacology · doi:10.1016/j.ccmp.2021.100010
Kabilan, S. J., Kunjiappan, S., Pavadai, P., Murugesan, S., & Sundar, K. (2025) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2025-0011
Metadata
- Authors
- Li, L., Kang, H., Zhang, Q., D’Agati, V. D., Al-Awqati, Q., & Lin, F.
- Affiliations
- Columbia University (US)
- Union Hospital (CN)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Lin, Fangming
- Venue
- Journal of Clinical Investigation
- Published
- 2019-05-06
- Volume
- 129
- Issue
- 6
- Pages
- 2374-2389
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC6541430
- OpenAlex
- W2923585401
- Cited by
- 105
- References
- 81
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 11 · 2023: 13 · 2022: 18 · 2021: 25 · 2020: 19 · 2019: 6
- FWCI
- 13.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (R00CA160351, R01CA211732)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK107653)
- Topics
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- FOXO3, chronic kidney disease, acute kidney injury, renal ischemia, prolyl hydroxylase, HIF-1α, transcription factor activation, interstitial fibrosis, autophagy, oxidative stress, renal tubular injury, capillary rarefaction
- MeSH terms
- Forkhead Box Protein O3, Autophagic Cell Death, Animals, Fibrosis, Kidney Tubules, Mice, Transgenic, Cell Hypoxia, Oxidative Stress, Mice, Renal Insufficiency, Chronic, Acute Kidney Injury
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.